2591947
|
24
|
|
FL
|
|
Recovered
|
4302MFZ3
|
2023-03-03
|
|
2593152
|
40
|
|
NY
|
|
|
4302MF028
|
2023-03-02
|
1
|
2587377
|
40
|
|
|
|
|
|
2023-02-23
|
2
|
2585716
|
44
|
|
CA
|
|
Recovered
|
4302MF023
|
2023-02-22
|
0
|
2583975
|
20
|
|
GA
|
|
|
|
2023-02-17
|
0
|
2588686
|
18
|
|
NC
|
|
Recovered
|
|
2023-02-17
|
1
|
2582595
|
33
|
|
FL
|
- Chest pain
- Dyspnoea
- Palpitations
|
|
4302MF023
|
2023-02-13
|
|
2591951
|
53
|
|
FL
|
|
Recovered
|
4302MF023
|
2023-02-13
|
6
|
2578989
|
71
|
|
WA
|
- Bone pain
- Injection site pain
|
Recovered
|
4302MF023
|
2023-02-09
|
0
|
2580311
|
29
|
|
AZ
|
- Dizziness
- Headache
- Immediate post-injection reaction
- Pain
- Pain in extremity
|
Recovered
|
4302MF023
|
2023-02-08
|
0
|
|
2583969
|
38
|
|
MT
|
|
|
4302MF023
|
2023-02-01
|
1
|
2571273
|
25
|
|
NC
|
- Fatigue
- Headache
- Injection site pruritus
- Lymphadenopathy
- Myalgia
- Pain in extremity
|
|
|
2023-01-28
|
1
|
2570597
|
34
|
|
CT
|
- Back pain
- Diarrhoea
- Dyspnoea
- Nausea
|
|
1302MF023
|
2023-01-27
|
|
2574238
|
44
|
|
NE
|
- Blood test normal
- Bradyphrenia
- Chills
- Confusional state
- Cyanosis
- Dysarthria
- Impaired driving ability
- Influenza virus test negative
- Lethargy
- Muscle fatigue
- Myalgia
- Pallor
- Pyrexia
- SARS-CoV-2 test negative
|
|
4302MF023
|
2023-01-27
|
1
|
2568827
|
18
|
|
CA
|
- Incorrect dose administered
- No adverse event
|
Recovered
|
4302MF023
|
2023-01-24
|
|
2571265
|
33
|
|
NV
|
|
|
|
2023-01-17
|
0
|
2568531
|
54
|
|
RI
|
- Hyperhidrosis
- Parosmia
- Pyrexia
|
|
NDC806310100
|
2023-01-14
|
2
|
2573344
|
60
|
|
AL
|
- Blood pressure fluctuation
- Chest X-ray normal
- Condition aggravated
- Feeling hot
- Heart rate increased
- Laboratory test normal
- Tachycardia
|
|
4302MF023
|
2023-01-14
|
4
|
2564621
|
60
|
|
FL
|
- Computerised tomogram
- Diplopia
- Dizziness
- Dysstasia
- Hypotension
- Nausea
- Neurological symptom
- Transient ischaemic attack
- Vomiting
|
Hospitalized Life Threatening
|
|
2023-01-12
|
3
|
2563459
|
22
|
|
WI
|
|
|
4302MF023
|
2023-01-07
|
1
|
2549474
|
24
|
|
|
- Immediate post-injection reaction
- Muscular weakness
- Nausea
- Paraesthesia
|
Recovered
|
4302MF023
|
2023-01-03
|
0
|
2580375
|
40
|
|
AR
|
- Dizziness
- Migraine
- Myalgia
- Nausea
|
|
4302MF023
|
2023-01-01
|
0
|
2563335
|
26
|
|
FL
|
- Migraine
- Nausea
- Phonophobia
- Photophobia
- Vomiting
|
|
|
2022-12-28
|
3
|
2544305
|
34
|
|
CA
|
- Expired product administered
- Product storage error
|
|
4302MF023
|
2022-12-27
|
0
|
2585604
|
42
|
|
WV
|
|
|
4302MF023
|
2022-12-27
|
0
|
2545078
|
26
|
|
CA
|
- Dizziness
- Fatigue
- Somnolence
- Tremor
- Vertigo
|
Recovered
|
4302MF023
|
2022-12-22
|
0
|
2535569
|
30
|
|
ID
|
- Chest discomfort
- Chest pain
- Dizziness
- Nausea
|
|
4302MF023
|
2022-12-13
|
1
|
2533435
|
17
|
|
OH
|
- Blood magnesium normal
- Blood phosphorus normal
- Computerised tomogram head normal
- Electrocardiogram normal
- Full blood count normal
- Loss of consciousness
- Malaise
- Metabolic function test
- Retching
- Seizure
- Tremor
|
Recovered
|
4303MF023
|
2022-12-13
|
1
|
2550819
|
27
|
|
NY
|
- Fatigue
- Heart rate increased
- Injection site pain
- Rash
- Skin warm
|
|
4302MF023
|
2022-12-13
|
0
|
2528858
|
64
|
|
MO
|
- Interchange of vaccine products
|
Recovered
|
4302MF023
|
2022-12-12
|
0
|
2531066
|
54
|
|
|
- Immunisation reaction
- Pruritus
- Rash macular
|
|
4302MF023
|
2022-12-12
|
0
|
2554789
|
60
|
|
FL
|
- Injection site reaction
- Scab
- Wound
|
|
4302MF023
|
2022-12-08
|
|
2537490
|
55
|
|
NH
|
|
|
4302MF023
|
2022-12-07
|
|
2523054
|
64
|
|
IL
|
- Interchange of vaccine products
- No adverse event
|
|
4302MF023
|
2022-12-05
|
0
|
2522736
|
55
|
|
OK
|
- Injected limb mobility decreased
- Injection site erythema
- Injection site pain
- Injection site rash
- Lymphadenopathy
- Pain
|
|
|
2022-12-02
|
1
|
2539427
|
35
|
|
VA
|
- Incorrect product formulation administered
|
Recovered
|
FR2583
|
2022-12-02
|
0
|
2535766
|
48
|
|
FR
|
- Body temperature
- Haematemesis
|
Hospitalized
|
GJ1842
|
2022-12-02
|
7
|
2522471
|
20
|
|
CO
|
- Headache
- Injection site induration
- Injection site swelling
- Malaise
- Myalgia
- Pyrexia
- Rash erythematous
- Wrong product administered
|
|
|
2022-12-01
|
1
|
2520904
|
33
|
|
CA
|
|
Recovered
|
4302MF023
|
2022-11-30
|
0
|
2522544
|
47
|
|
CA
|
- Inflammation
- Injection site pain
- Myalgia
- Pain
|
|
4302MF023
|
2022-11-30
|
0
|
2557795
|
33
|
|
|
|
|
4302MF023
|
2022-11-30
|
0
|
2527711
|
66
|
|
PR
|
- Incorrect dose administered
|
|
4302MF02
|
2022-11-22
|
0
|
2527737
|
61
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2527981
|
80
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2527993
|
61
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2528367
|
75
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2528375
|
78
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2528644
|
61
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2528649
|
54
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|
2528745
|
53
|
|
PR
|
- Incorrect dose administered
- Incorrect product formulation administered
|
|
4302MF02
|
2022-11-22
|
0
|